Skip to content
Magnus Esssand

Image -

Magnus Esssand

Magnus Essand, Professor at the Department of Immunology, Genetics and Pathology, Uppsala University
Mikael Wallerstedt
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
By:
Mikael Wallerstedt
File format:
.jpg
Size:
7086 x 4718, 5.27 MB
Download

Contacts

Elin Bäckström

Press contact Press Officer Research Education +46-70-425 09 83

Linda Koffmar

Press contact Press Officer +46 (0)18-471 19 59

Sandra Gunnarsson

Press contact Press Officer +4673 469 75 92

Related content

AAV-LIGHT therapy changes the phenotype of the tumor vessels and enable T cell infiltration into the tumor. Created with Biorender.

New therapy helps immune system eradicate brain tumours

Researchers from Uppsala University have developed a method that helps immune cells exit from blood vessels into the tumour and kill cancer cells. The aim is to improve treatment of aggressive brain tumours. The study has been published in the journal Cancer Cell.

Uppsala University - quality, knowledge, and creativity since 1477

Founded in 1477, Uppsala University is the oldest university in Sweden. With more than 50,000 students and 7,500 employees in Uppsala and Visby, we are a broad university with research in social sciences, humanities, technology, natural sciences, medicine and pharmacology. Our mission is to conduct education and research of the highest quality and relevance to society on a long-term basis. Uppsala University is regularly ranked among the world’s top universities.

Uppsala University

Dag Hammarskjölds väg 7
BOX 256, 751 05 Uppsala
Sweden